These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8579108)

  • 1. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
    Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
    Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive loss of CD44 gene expression in invasive bladder cancer.
    Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
    Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
    Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
    Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
    Weber B; Rösel M; Arch R; Möller P; Zöller M
    Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
    Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
    Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G; Jennings T; Robinson L; Ross JS; Figge J
    Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
    Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
    J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
    Iczkowski KA; Bai S; Pantazis CG
    Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-acting factors regulate the expression of CD44 splice variants.
    Konig H; Moll J; Ponta H; Herrlich P
    EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CD44 expression during carcinogenesis of the mouse colon.
    Rudzki Z; LeDuy L; Jothy S
    Exp Mol Pathol; 1997 Apr; 64(2):114-25. PubMed ID: 9316589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.